Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis

FHS
March 14, 2024
10:03 am

The performance of two commercial phospho-tau217 (p-tau217) assays.

Coalition wages campaign for retractions of Richard Lynn’s racist journal articles

A coalition of researchers, historians, and journalists is urging that major scientific publishers, including Elsevier and Springer, retract the racist articles of an academic known

June 20, 2024

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson’s progression

A recent study in Nature Medicine evaluated the efficacy of prasinezumab, a monoclonal antibody, in slowing the progression of motor symptoms in Parkinson’s disease patients

April 19, 2024

In year 6, KFF Health News-NPR’s ‘Bill of the Month’ helps patients in a changing system

In 2023, our nationwide reporting team has been hard at work on a holiday gift to you: a packet of advice for navigating the labyrinthine

December 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.